Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Reducing patient drug acquisition costs can lower diabetes health claims.

Mahoney JJ.

Am J Manag Care. 2005 Aug;11(5 Suppl):S170-6.

2.
3.

Implications of an SSRI generic step therapy pharmacy benefit design: an economic model in anxiety disorders.

Panzer PE, Regan TS, Chiao E, Sarnes MW.

Am J Manag Care. 2005 Oct;11(12 Suppl):S370-9.

4.

Costs and utilization associated with pharmaceutical adherence in a diabetic population.

Hepke KL, Martus MT, Share DA.

Am J Manag Care. 2004 Feb;10(2 Pt 2):144-51.

5.

Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.

Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL.

Clin Ther. 2006 Oct;28(10):1712-25; discussion 1710-1. Erratum in: Clin Ther. 2006 Nov;28(11):1968-9.

PMID:
17157128
6.

Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit.

Rodin HA, Heaton AH, Wilson AR, Garrett NA, Plocher DW.

Am J Manag Care. 2009 Dec;15(12):881-8.

7.

Effects of benefit design change across 5 disease states.

Brixner DI, Joish VN, Odera GM, Avey SG, Hanson DM, Cannon HE.

Am J Manag Care. 2007 Jun;13(6 Pt 2):370-6.

9.

Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemia.

Darkow T, Henk HJ, Thomas SK, Feng W, Baladi JF, Goldberg GA, Hatfield A, Cortes J.

Pharmacoeconomics. 2007;25(6):481-96.

PMID:
17523753
10.

Healthcare utilization and costs of patients with rosacea in an insured population.

Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G.

J Drugs Dermatol. 2008 Jan;7(1):41-9.

PMID:
18246697
11.

Formulary: what it is and how it works.

Smith G.

J Healthc Resour Manag. 1996 Sep;14(7):11-3.

PMID:
10161584
12.

Economic impacts attributable to the early clinical benefit of atorvastatin therapy--a US managed care perspective.

Straka RJ, Mamdani M, Damen J, Kuntze CE, Liu LZ, Botteman MF, Koren MJ.

Curr Med Res Opin. 2007 Jul;23(7):1517-29.

PMID:
17535539
13.

Economic costs of diabetes in the U.S. In 2007.

American Diabetes Association.

Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Review. Erratum in: Diabetes Care. 2008 Jun;31(6):1271.

PMID:
18308683
14.

Predictors of satisfaction of health plan members with prescription drug benefits.

Motheral BR, Heinle SM.

Am J Health Syst Pharm. 2004 May 15;61(10):1007-14.

PMID:
15160776
15.

Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.

Davis KL, Candrilli SD, Edin HM.

Epilepsia. 2008 Mar;49(3):446-54. Epub 2007 Nov 21.

16.

Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study.

Tseng CW, Tierney EF, Gerzoff RB, Dudley RA, Waitzfelder B, Ackermann RT, Karter AJ, Piette J, Crosson JC, Ngo-Metzger Q, Chung R, Mangione CM.

Diabetes Care. 2008 Feb;31(2):261-6. Epub 2007 Nov 13.

17.

Impact of a managed-Medicare physical activity benefit on health care utilization and costs in older adults with diabetes.

Nguyen HQ, Ackermann RT, Berke EM, Cheadle A, Williams B, Lin E, Maciejewski ML, LoGerfo JP.

Diabetes Care. 2007 Jan;30(1):43-8.

PMID:
17192331
18.

Labor characteristics and program costs of a successful diabetes disease management program.

Rothman RL, So SA, Shin J, Malone RM, Bryant B, Dewalt DA, Pignone MP, Dittus RS.

Am J Manag Care. 2006 May;12(5):277-83.

19.

Evaluation of value-based insurance design with a large retail employer.

Kim YA, Loucks A, Yokoyama G, Lightwood J, Rascate K, Serxner SA.

Am J Manag Care. 2011 Oct;17(10):682-90.

PMID:
22106461
20.

A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes.

Borah BJ, Darkow T, Bouchard J, Aagren M, Forma F, Alemayehu B.

Clin Ther. 2009 Mar;31(3):623-31. doi: 10.1016/j.clinthera.2009.03.005.

PMID:
19393853

Supplemental Content

Support Center